Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Not yet recruitingOBSERVATIONAL

Enrollment

240

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions

PneumocystisImmunocompromised Patients

Interventions

OTHER

Biological sampling

Mouthwash, nasopharyngeal swab, blood sampling

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06890078 - Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients | Biotech Hunter | Biotech Hunter